Table 3.

List of drugs that have been used to mitigate COVID -19.

S.N.	Drugs	Brand Name	Manufacturer	Dose	Duration of treatment	References
1.	Lopinavir/ritonavir	Aluvia®	ABBOTT health care Pvt. Ltd.	50 mg/20 0 mg in tablet form	Not more than 10 days	Dong et al. (2020)
2.	Ribavirin	Rebetol, Ribasphere, Copegus and Virazole	Valeant Pharmaceuticals	500 mg thrice a day or given in combination with ritonavir/Lopinavir and INF-α through Intravenous infusion	Not more than 10 days	Dong et al. (2020)
3.	Chloroquine phosphate	Aralen	Novartis, Mylan and Teva	500 mg, 250 mg twice a day given orally	Not more than 10 days	Dong et al. (2020)
4.	Umifenovir	Arbidol	Pharmastandart	50 mg, 200 mg thrice a day in oral form	Not more than 10 days	Dong et al. (2020)
5.	Oseltamivir	ANTIFLU cap	Cipla	75 mg twice in a day in oral form	3–14 days	(file:///C:/Users/hp/Downloads/Tamiflu_GL-019936.pdf)
6.	Umifenovir	Arbidol	Pharmastandart	0.2 g three times a day	Not more than 14 days	Zhu et al. (2020)
7.	Baricitinib	Olumiant	Eli Lilly	2 mg once daily	Not more than 14 days	(Richardson et al., 2020a, 2020b; Stebbing et al., 2020)
8.	Bromhexine	BROLYT	Alco Pharma Ltd.	4 mg and 8 mg three times a day	–	Rosa and Santos (2020)
9.	Fingolimod	Gilenya	Novartis	0.5 mg once in a day	Not more than 3 days	(https://clinicaltrials.gov/ct2/show/NCT04280588)
10.	Bevacizumab	Avastin	Aspar Pharmaceuticals	500 mg	–	(https://clinicaltrials.gov/ct2/show/NCT04275414)
11.	Pirfenidone	Esbriet	Glenmark Pharmaceuticals	267 mg three times a day	–	(https://clinicaltrials.gov/ct2/show/NCT04282902)
12.	Thalidomide	Thalomid	Grunenthal	100 mg	Not more than 14 days	(https://clinicaltrials.gov/ct2/show/NCT04273529)